Weight Management Research
To learn more about obesity, overweight and ongoing clinical trials in the area, visit our Weight Management Research page.
Learn MoreThis study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additional evidence for the potential clinical benefits of tirzepatide in this population.
Be overweight or have obesity
Are over age 40 and have heart disease at least 3 months before study start
Women at least 55 years of age without established heart disease but have cardiovascular risk factors, such as smoke tobacco, abnormal levels of fats (lipids) in the blood, high blood pressure, kidney disease, or high sugar levels.
Men at least 50 years of age without established heart disease but have cardiovascular risk factors, such as smoke tobacco, abnormal levels of fats (lipids) in the blood, high blood pressure, kidney disease, or high sugar levels.
Have type 1 diabetes or type 2 diabetes at the beginning of the study
Have any of the cardiovascular conditions such as: heart attack, stroke, procedure to treat coronary artery disease, or heart failure requiring IV medication or left ventricular assist device. 3 months before the start of the study
To learn more about obesity, overweight and ongoing clinical trials in the area, visit our Weight Management Research page.
Learn MoreLearn how Lilly is working with health care partners to improve diversity in our clinical studies.
Watch the VideoA clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.